All Outputs (2)

Novel nonadride, heptadride and maleic acid metabolites from the byssochlamic acid producer Byssochlamys fulva IMI 40021-an insight into the biosynthesis of maleidrides (2015)
Journal Article
Szwalbe, A. J., Williams, K., O'Flynn, D. E., Bailey, A. M., Mulholland, N. P., Vincent, J. L., …Simpson, T. J. (2015). Novel nonadride, heptadride and maleic acid metabolites from the byssochlamic acid producer Byssochlamys fulva IMI 40021-an insight into the biosynthesis of maleidrides. Chemical Communications, 51(96), 17088-17091. https://doi.org/10.1039/c5cc06988b

The filamentous fungus Byssochlamys fulva strain IMI 40021 produces (+)-byssochlamic acid 1, its novel dihydroanalogue 2 and four related secondary metabolites. Agnestadrides A, 17 and B, 18 constitute a novel class of seven-membered ring, maleic anh... Read More about Novel nonadride, heptadride and maleic acid metabolites from the byssochlamic acid producer Byssochlamys fulva IMI 40021-an insight into the biosynthesis of maleidrides.

Mouse mammary stem cells express prognostic markers for triple-negative breast cancer (2015)
Journal Article
Soady, K. J., Kendrick, H., Gao, Q., Tutt, A., Zvelebil, M., Ordonez, L. D., …Smalley, M. J. (2015). Mouse mammary stem cells express prognostic markers for triple-negative breast cancer. Breast Cancer Research, 17(1), Article 31. https://doi.org/10.1186/s13058-015-0539-6

Introduction: Triple-negative breast cancer (TNBC) is a heterogeneous group of tumours in which chemotherapy, the current mainstay of systemic treatment, is often initially beneficial but with a high risk of relapse and metastasis. There is currently... Read More about Mouse mammary stem cells express prognostic markers for triple-negative breast cancer.